Camena Bioscience is a startup based in the United Kingdom, most recent round Series A, 1 tracked investor.
Camena Bioscience is a company founded in 2016 headquartered in the United Kingdom. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Camena Bioscience is a biotechnology company specializing in DNA synthesis. Their gSynth platform aims to provide long and complex DNA sequences with high accuracy and speed, enabling advancements in various fields such as drug discovery and synthetic biology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.